Published in Verh Dtsch Ges Inn Med on June 12, 1978
Specific suppression of the antibody response by antibodies to receptors. Proc Natl Acad Sci U S A (1972) 3.02
Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science (1972) 2.73
[Virus proteins. IV. Constitution of the coat protein of the fd phage]. Hoppe Seylers Z Physiol Chem (1969) 2.56
Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa. One gene codes for both the cytosolic and mitochondrial forms. J Biol Chem (1988) 2.43
Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med (1999) 2.14
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction (2003) 2.06
Regulation of immune response by autogenous antibody against receptor. Proc Natl Acad Sci U S A (1974) 2.05
[Fever of uncertain origin]. Internist (Berl) (1994) 2.02
Incidence and frequency or complications and management of Meckel's diverticulum. Surg Gynecol Obstet (1989) 1.98
Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc Natl Acad Sci U S A (1991) 1.97
Dose- and sex-independent disposition of ciprofloxacin. Eur J Clin Microbiol (1984) 1.82
Specific suppression of immune responses. Science (1973) 1.67
Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock. Intensive Care Med (2001) 1.66
Macroglobulin structure: homology of mu and gamma heavy chains of human immunoglobulins. Science (1969) 1.64
Neonatal tolerance induced by antibody against antigen-specific receptor. Science (1974) 1.61
Cephalosporin-induced encephalopathy in uremic patients. Nephron (1988) 1.60
CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int (2007) 1.58
[Use of drugs in residents of homes for the elderly and nursing homes in comparison with patients in ambulatory care or without need of care]. Dtsch Med Wochenschr (2002) 1.54
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation (2001) 1.54
Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets. Proc Natl Acad Sci U S A (1993) 1.54
Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine. Int J Clin Pharmacol Biopharm (1978) 1.50
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. Rheumatology (Oxford) (2008) 1.49
The response to phosphorylcholine: dissecting an immune response. Transplant Rev (1975) 1.49
Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. J Immunol (1992) 1.47
Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl (2001) 1.44
Suppression by autogenous complementary idiotypes: the priority of the first response. J Exp Med (1976) 1.43
A human flora-associated rat model of the breast-fed infant gut. J Pediatr Gastroenterol Nutr (2003) 1.43
Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J (1997) 1.43
Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics. Clin Pharmacokinet (1988) 1.42
Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature (1970) 1.41
Coronary anomaly in Behçet's syndrome. Rheumatol Int (1997) 1.40
Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant (1999) 1.40
[Innovation instead of imitation -- news in drug therapy]. Dtsch Med Wochenschr (2005) 1.39
Transposition of the great arteries with straddling tricuspid valve. Report of two rare cases with acquired subaortic stenosis after main pulmonary artery banding. J Thorac Cardiovasc Surg (1989) 1.39
[Quality assurance in bariatric surgery in Germany--results of the German multicentre trial 2005 and 2006]. Zentralbl Chir (2008) 1.38
[Fractures of vital teeth under chronic pain therapy with oxycodone]. Dtsch Med Wochenschr (2006) 1.38
PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am J Transplant (2008) 1.34
The aldolase-binding site of the human erythrocyte membrane is at the NH2 terminus of band 3. J Biol Chem (1981) 1.31
Preparation and analysis of seven major, topographically defined fragments of band 3, the predominant transmembrane polypeptide of human erythrocyte membranes. Biochemistry (1978) 1.30
Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest (1998) 1.30
[Sterno-costo-clavicular hyperostosis: a hitherto undescribed entity (author's transl)]. Dtsch Med Wochenschr (1975) 1.28
Import of cytochrome c into mitochondria. Cytochrome c heme lyase. Eur J Biochem (1987) 1.28
Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study. Pediatr Infect Dis J (1996) 1.28
Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. Klin Wochenschr (1982) 1.26
Clonal restriction of the immune response to phosphorylcholine. Nature (1974) 1.25
Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int (1986) 1.23
Interaction of cimetidine with metoprolol, propranolol, or atenolol. Lancet (1981) 1.22
Strategy for membrane protein crystallization exemplified with OmpA and OmpX. Proteins (1999) 1.21
Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci U S A (1993) 1.21
Anti-receptor antibody. II. Induction of long-term unresponsiveness in neonatal mice. J Immunol (1975) 1.19
[Mucolipidosis type II (I-cell disease) with unusually severe heart involvement]. Monatsschr Kinderheilkd (1987) 1.19
T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant (2000) 1.17
Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int (2001) 1.17
Sternocostoclavicular hyperostosis: painful swelling of the sternum, clavicles, and upper ribs. Report of two new cases. Ann Intern Med (1977) 1.16
Antihypertensive drug therapy and blood pressure control in men and women: an international perspective. J Hum Hypertens (2009) 1.16
Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am J Pathol (2000) 1.15
The cloven hoof in legal medicine. Int J Legal Med (2001) 1.15
Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant (1997) 1.15
Priapism during regular haemodialysis. Lancet (1974) 1.14
Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol (2008) 1.14
Clinical pharmacokinetics of articaine. Clin Pharmacokinet (1997) 1.13
Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int (1995) 1.12
Soft contact lens polymers: an evolution. Biomaterials (2001) 1.12
P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. Int J Clin Pharmacol Ther (2000) 1.10
Recognition and management of overweight and obesity in primary care in Germany. Int J Obes Relat Metab Disord (2004) 1.09
Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest (1987) 1.09
[Policy paper to the cardiac re-sychronization therapy]. Z Kardiol (2003) 1.09
Clonal depletion in neonatal tolerance. Science (1974) 1.08
Immune response to phosphorylcholine. III. Requirement of the Fc portion and equal effectiveness of IgG subclasses in anti-receptor antibody-induced suppression. J Immunol (1977) 1.08
The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol (1999) 1.08
Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis (1995) 1.07
[Significance of bladder puncture in the nephrological diagnosis]. Med Welt (1972) 1.07
B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV-1 infection. Scand J Immunol (1993) 1.06
Idiotypic networks and nature of molecular mimicry: an overview. Methods Enzymol (1989) 1.05
Comparative macrorestriction and RFLP analysis of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. hominissuis isolates from man, pig, and cattle. Vet Microbiol (2006) 1.05
Transmission and control of methicillin-resistant Staphylococcus aureus in a skilled nursing facility. Infect Control Hosp Epidemiol (1989) 1.05
Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis (2006) 1.05
Fetoscopic transesophageal electrocardiography and stimulation in fetal sheep: a minimally invasive approach aimed at diagnosis and termination of therapy-refractory supraventricular tachycardias in human fetuses. Circulation (1999) 1.04
An immunologic network. Contemp Top Immunobiol (1980) 1.04
Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC15 antibodies. J Immunol (1982) 1.04
Current trends in biocompatibility testing. Proc Inst Mech Eng H (1998) 1.03
Tobacco use among medical students in Europe: results of a multicentre study using the Global Health Professions Student Survey. Public Health (2011) 1.03
Serological evidence for reactivation of EBV infection due to uraemic immunodeficiency. Nephrol Dial Transplant (1997) 1.02
Ventricular aneurysm or diverticulum? Clinical differential diagnosis. Pediatr Cardiol (2001) 1.02
Adolescents' drug use and drug knowledge. Eur J Pediatr (2000) 1.01
Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol (2000) 1.01
Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol (1998) 1.00
Nitrocellulose-enzyme-linked immunosorbent assay (NC-ELISA) - a sensitive technique for the rapid visual detection of both viral antigens and antibodies. J Virol Methods (1984) 1.00
Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am J Transplant (2007) 1.00
Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. Clin Nephrol (1982) 1.00
Plasma arginine, citrulline, and ornithine kinetics in adults, with observations on nitric oxide synthesis. Am J Physiol (1995) 1.00
[Prevalence and pharmacotherapy of diabetes mellitus in primary care]. Dtsch Med Wochenschr (2005) 0.99
Refractory period, sensory conduction velocity and visual evoked potentials before and after haemodialysis. J Neurol Neurosurg Psychiatry (1981) 0.99
Studies on the regulation of enolases and compartmentation of cytosolic enzymes in Saccharomyces cerevisiae. Biochim Biophys Acta (1987) 0.99
In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients. Am J Kidney Dis (2000) 0.98
Combined MLST and AFLP typing of Bartonella henselae isolated from cats reveals new sequence types and suggests clonal evolution. Vet Microbiol (2010) 0.98
Light chain isotypes selectively associate with heavy chain idiotypes in T-dependent and T-independent dextran-specific precursors. Nature (1981) 0.98